Rafferty Asset Management, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1389426
New York, NY
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,158,945
-$1,614,258 QoQ
Shares Held
18,743
-48.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#257
of 773 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $21,876,011 across 22 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
48,590 | $3,491,677 | |
| 2 | ALKS |
Alkermes plc.
|
62,965 | $3,299,366 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
18,743 | $3,158,945 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
5,742 | $3,111,187 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
265,618 | $2,656,180 | |
| 6 | VTRS |
Viatris Inc
|
140,790 | $2,235,745 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
152,878 | $643,616 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
16,555 | $407,418 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,158,945 | 18,743 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,773,203 | 36,232 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,539,170 | 39,055 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,240,446 | 58,701 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,947,860 | 79,146 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,149,254 | 100,807 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $14,607,001 | 107,011 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,227,008 | 140,835 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,933,134 | 122,998 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,084,790 | 65,870 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,086,096 | 76,549 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $9,167,625 | 81,490 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,395,623 | 89,031 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,185,405 | 70,988 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,200,033 | 68,654 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,917,351 | 65,129 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,938,386 | 40,402 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,615,250 | 59,896 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,638,254 | 66,200 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,089,644 | 32,214 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,574,114 | 26,450 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,339,176 | 34,336 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $990,513 | 10,334 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,900,698 | 19,766 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,359,690 | 11,145 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $370,520 | 4,281 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||